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In Vitro Generation of Lymphohematopoietic Cells
from Endothelial Cells Purified from Murine Embryos
YS either by mechanical dissociation or collagenase
treatment, which are not sufficient to dissociate cells
from the organized EC layer. However, histological find-
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Hiroshi Kawamoto,² Hisahiro Yoshida,*
Masami Kizumoto,* Hiroshi Kataoka,*
ings that HPC appeared to bud from the luminal wall ofand Yoshimoto Katsura²
the developing vascular system (Smith and Glomski,*Department of Molecular Genetics
1982; Tavian et al., 1996) suggested that some EC, evenFaculty of Medicine
after being integrated in the EC layer, can give rise to²Department of Immunology
HPC. If such hematopoietic EC exist, the analysis of theChest Disease Research Institute
lymphopoietic potential of various tissues should beKyoto University
extended to EC. Histological observation, however, isShogoin-kawaharacho 53, Sabyo-ku
not sufficient to prove the presence of hematopoieticKyoto 606-8507
EC, because it is difficult to distinguish whether HPCJapan
bud from EC or circulating HPC somehow adhere to EC.
The first aim of this study is to investigate whether or
not hematopoietic EC exist in the earliest hematopoietic
Summary tissues, such as YS and theaorta-gonado-mesonephros
region (AGM). If they do, then the next aim is to investi-
We have investigated the lymphohematopoietic po- gate the lymphopoietic potential of EC in the YS and
tentials of endothelial cells (EC) and hematopoietic the embryo proper. In order to measure hematopoietic
cells (HPC) sorted from embryos. Expression of VE- potential of EC, however, it is essential to purify EC with
cadherin, CD45, and Ter119 was used to distinguish surface markers distinguishing EC from HPC and also
EC (VE-cadherin1CD452Ter1192) from HPC (VE-cad- from earlier pluripotent mesoderm. According to previ-
herin2CD451). Thus defined, EC population takes up ous findings that VE-cadherin (VE-cad) is expressed ex-
acetylated LDL and coexpresses CD31, Flk1, and CD34. clusively in EC and plays an essential role in maintaining
In E9.5 embryos, EC from yolk sac (YS) and the embryo the integrity of theEC layer (Ayalon et al., 1994; Lampug-
proper generate blood cells, including lymphocytes. nani et al., 1995; Matsuyoshi et al., 1997; Vittet et al.,
Thus, lymphohematopoietic EC do exist in the embryo, 1997), we sought to purify EC by surface staining with
and they are generated both in YS and the embryo anti-VE-cad monoclonal antibodies (mAb).
proper. On the other hand, HPC with lymphopoietic In this report, we show that VE-cad is indeed ex-
potency appear first in the embryo proper. These find- pressed specifically in EC. VE-cad1CD452Ter1192 cells
sorted by fluorescence-activated cell sorter (FACS) fromings implicate involvement of multiple environmental
either YS or the caudal half of the embryo proper cancues for acquiring lymphopoietic competency during
give rise to lymphohematopoietic cells, providing thedifferentiation of HPC.
first evidence for the presence of lymphohematopoietic
EC. Surprisingly, the lymphopoietic potential of embry-Introduction
onic day (E) 9.5 YS is enriched in the VE-cad1 fraction
rather than the CD451 or Ter1191 HPC fraction. OurControversy regarding the first site of the generation of
results indicate that the lymphohematopoietic poten-hemopoietic cells (HPC) with lymphohemogenic po-
tials of YS and the caudal half of the embryo proper,tency has raged for three decades, resurfacing when-
including the AGM region, differ at the HPC level, whileever innovations have been introduced in measuring the
they are basically the same at the EC level. Hence, thispotency of HPC (Moore and Owen, 1967; Johnson and
study may help to settle the 30-year controversy on theMoore, 1975; Weissman et al., 1978; Ogawa et al., 1988;
lymphohematopoietic potency of YS cells.Muller et al., 1994; Cumano et al., 1996; Medvinsky and
Dzierzak, 1996; Dieterlen-Lievre et al., 1997; Yoder et
Resultsal., 1997a, 1997b). It is surprising that conflicting notions
have survived this long, considering that the issue is a
VE-Cadherin Expression in Early Embryos
simple one: whether or not HPC in the yolk sac (YS)
A previous study indicated that VE-cadherin is ex-
display the cell autonomous potential to give rise to
pressed exclusively in EC (Breier et al., 1996). To assess
the definitive hematopoietic stem cells. In this regard, this notion using our own mAb, E7.5 and 9.5 embryos
experiments with positive results emphasize the impor- were immunostained with anti-VE-cadherin mAb VECD1
tance of experimental conditions for generating lympho- (Figure 1). In the early head streak stage (E7.5), when
cytes, whereas those with negative results stress the VE-cad was reported to be first expressed (Breier et al.,
potential interchange of stem cells by the embryonic 1996), VE-cad1 cells appeared to constitute a small part
circulation. In neither case, however, has the possibility of the Flk11 cells that are distributed over the extraem-
that endothelial cells (EC) bear the potential to give rise bryonic and lateral regions of embryos (Figures 1A and
to lymphohemopoietic lineages been considered. There- 1B). VE-cad was expressed in the cells that had already
fore, all previous studies prepared cell suspensions from been organized to form a vascular plexus, while Flk11
cells were still distributed diffusely with a dot-like pat-
tern. This pattern suggests that VE-cad expression coin-³To whom correspondence should be addressed (e-mail: snishika@
virus.kyoto-u.ac.jp). cides well with the formation of vascular structure, while
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staining was found in the extraluminal space. These
results agree with the conclusion of a previous study
that VE-cad is expressed exclusively in EC (Breier et
al., 1996), while Flk11 cells include mesoderm, EC, and
some hematopoietic cells. Another marker, CD31 (plate-
let endothelial cell adhesion molecule), that has often
been used for marking EC, was expressed also in non-
mesoderm-derived cells (Lampugnani et al., 1993; our
unpublished data).
Surface Phenotypes of VE-Cad1 Cells
Since whole-mount immunostaining may not be suffi-
cient to detect a small number of VE-cad1 cells that
coexpress HPC markers, we next analyzed expression
of other surface markers on VE-cad1 cells using FACS.
Single cell suspensions were prepared from various
stages of embryos (Figure 2) by sequential treatment
with dispase and EDTA/EGTA. Without this treatment,
the VE-cad1 EC fraction could not be recovered, indicat-
ing that most VE-cad1 cells are indeed organized in the
EC layer by adherence junction.
CD451 cells were detected earlier in YS than the em-
bryo proper (in this study the embryo proper stands for
the caudal half of the embryo lower than heart level),
implicating YS as the first site of HPC generation. CD34
expression was detected in both CD451 and VE-cad1
populations, and virtually all CD341 cells present in em-
bryos younger than E9.5 coexpressed c-Kit as well.
Upon generation of differentiated HPC, c-Kit2 CD341
appeared. In contrast to CD34 expression in the CD451
population, VE-cad-expression and CD45-expression
are mutually exclusive before E9.5 (Figure 2), though
Figure 1. Immunolocalization of VE-Cad in Embryos some Mac11 monocytes appearing later than E10.5 ex-
Early head fold stage embryos were dissected and whole-mount pressed VE-cad. In order to confirm EC lineage of VE-
immunostained either with anti-VE-cad (A) or anti-Flk1 (B). As com- cad1 cells, cells dissociated from YS and the caudal
pared with diffuse dot-like expression of Flk in the extraembryonic
half of E9.5 embryos were pooled, first incubated withand lateral plate regions, VE-cad1 cells are already organized in the
DiI-acetylated LDL, and subsequently stained by APC-plexus-like structure. Colocalization of VE-cad to vascular struc-
anti-VE-cad and fluorescein isothiocyanate (FITC)-labeledtures becomes conspicuous in the YS of E8.5 embryos (C). YS of
E9.5 embryos were stained either with anti-Flk1 (D and E) or anti- anti-CD31, anti-Flk1, or anti-CD34 mAb. As shown in
VE-cad mAb (F and G). At this stage, Flk1 colocalize largely to Figure 3, almost all VE-cad1 cells shifted to the right
vascular structures, though many round cells in the luminal space with these mAb or incubation with DiI-acetylated LDL,
(E, indicated by white asterisks) were also positive. In contrast,
indicating that virtually all VE-cad1 cells coexpress CD31,those round cells were negative for VE-cad expression (G, indicated
Flk1, and CD34 and take up acetylated LDL. In theseby white asterisks). Thus, VE-cad is expressed exclusively in the
criteria, thus, VE-cad1 cells represent functional EC.EC, particularly in the cell±cell junctions of EC (arrows in G).
Flk1 marks both mesoderm and EC in the gastrulating Colony Formation of VE-Cad1 Cells in Response
to Hematopoietic Growth Factorsembryo. Indeed, previous studies demonstrated that
Flk1 is expressed in the nascent proximal lateral meso- In order to investigate whether or not hematopoietic EC
exists, cells dissociated from YS and the caudal half ofderm of E7.0 embryos before expression of VE-cad (Ka-
taoka et al., 1997; Nishikawa et al., 1998). E9.5 embryos were pooled, incubated with DiI-acety-
lated LDL, and subsequently stained with APC-labeledWhole-mount immunostaining of E8.5 embryo (Figure
1C) and YS of E9.5 embryos (Figures 1F and 1C) with anti-VE-cad and FITC-labeled anti-CD31. Triple-positive
cells were sorted and subjected to colony assay in type Ianti-VE-cad mAb displayed clearly that VE-cad expres-
sion localized exclusively in the vascular system and collagen gel containing SCF, interleukin-3 (IL-3), G-CSF,
and erythropoietin. While no colony was generated inthat it was concentrated at the adherence junctions of
EC (arrows in Figure 1G). At this stage, Flk1 expression the culture without growth factors, 277 colonies were
generated in cultures containing 2500 sorted cells andalso localized to the vascular endothelial cells (Figures
1D and 1E), though some round cells in the vascular the growth factor mixture. Thus, more than 10% of VE-
cad1 CD311 cells incorporating acetylated LDL can formlumens (indicated by asterisk in Figure 1E) were Flk11.
In contrast, round HPC present within the luminal space colonies in response to the growth factor mixture. Both
compact and diffuse colonies were found (Figures 4A(indicated by asterisk in Figure 1G) were VE-cad2. No
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Figure 2. Surface Expression of VE-Cad, CD34, and CD45 in Embryos
YS and the caudal half of the embryo proper were dissected from E8.5, 9.5, and 10.5 embryos, and single cell suspensions were prepared.
Cells were stained with mixtures of mAb conjugated to different fluorescence dyes and analyzed by FACS Vantage. Only living cells excluding
propidium iodide were analyzed. Because of the variation in cell recoveries, the percentages presented in each panel may not represent the
actual proportion of each subset in embryos. Note that all CD451 cells in early embryos are CD341, whereas almost none of the CD451 cells
in E9.5 YS and the embryo proper are VE-cad1. CD451 cells are detected earlier in YS than in the embryo proper. From E8.5 to E10.5, all VE-
cad1 cells coexpress CD34. Most cells dissociated from E8.5 embryo expressed low levels of c-Kit, while it is down-regulated within the next
24 hr.
and 4B). After making a thin film of the collagen gel, a mixture of CD451 and Ter1191 cells (Lin1 cells) from
the embryo proper generated B2201 cells, those fromcolonies were stained in situ by May-GruÈ nwald-Giemsa
YS did not. Hence, as far as E9.5 YS cells are concerned,to evaluate morphology of cells. In compact colonies,
lymphopoietic potential is enriched in the VE-cad1 frac-most cells were mononuclear (Figures 4C and 4D),
tion rather than the Lin1 fraction. Moreover, failure towhereas in diffuse colonies, either monocytes or poly-
generate B2201 cells from the Lin1 fraction indicatedmorphonuclear cells with doughnut-shaped nuclei (Fig-
that thegeneration of B lineage cells from the EC fractionures 4E and 4F) were found. This is the first demonstra-
could not be due to contamination of HPC.tion of the existence of hematopoietic EC.
Since similar results were obtained in three indepen-
dent experiments, including that presented in Figure 6,B Lymphopoietic Potential of the EC Fraction
B lymphogenic HPC appears earlier in AGM than YS,
After defining EC as VE-cad1CD452Ter1192, we next
though the activity of EC is the same between the two
investigated the lymphohematogenic potential of EC regions.
and HPC sorted from YS and the caudal half of E8.5, Presence of B lineage cells in cultures was also con-
9.5, and 10.5 embryos. Lymphohematogenic potency firmed by room temperature polymerase chain reaction
was assessed in a culture containing OP9 stromal cells (RT-PCR) analysis of RAG1 and MB1 expression (Figure
and IL-7 as described by Nakano et al. (1994). 6). Consistent with the results of FACS analysis, expres-
EC from both YS and the caudal half of E8.5 embryos sion of RAG1 and MB1 in the culture of HPC from the YS
gave rise to Gr11 myelo-macrophage cell lineage (Figure was weak, whereas cultures of three other cell fractions
5A). Ter1191 erythroid cells could also be detected in were positive.
these cultures, when the cells were cultured in the pres- We also investigated whether or not our failure to detect
ence of erythropoietin and analyzed on day 5 of the B lymphogenic potential in the Lin1 fraction of E9.5 YS is
culture (data not shown). B2201 cells were not detected an outcome of suppressive activity of Ter1191 erythroid
in any cultures of cells from E8.5 embryos, be it from cells on B lymphocyte differentiation, as they constitute
YS or the embryo proper. On the other hand, EC from the major population in the unsorted or Lin1 populations
both the caudal half and YS of E9.5 embryos grew exten- of YS. In this particular experiment, CD451 rather than
sively and gave rise to B2201cells, most of which were Lin1 cells were purified and cultured under the same
conditions. 80-fold fewer B2201 cells were recoveredIL-7Ra1 and some already sIgM1 (Figure 5B). Although
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Figure 3. Expression of Vascular Markers in VE-Cad1 Cells
YS and the caudal half of E9.5 embryos were dissected, pooled,
and dissociated. The cells were incubated for 4 hr in the absence or
presence of DiI-acetylated LDL (10 mg/ml) at 378C and subsequently
stained with APC-anti-VE-cad and FITC-anti-CD31, FITC-anti-Flk1,
Figure 4. Colony Formation of VE-Cad1 Cells in Response to Hema-or FITC-anti-CD34 mAb. VE-cad1 cells were gated, and expression
topoietic Growth Factorsof each marker was analyzed in the gated population. Dotted lines
represent the controls for PE and FITC, without DiI-acetylated LDL YS and the caudal half of E9.5 embryos were dissected, pooled, and
incubation and with FITC-anti-mouse-IgG, respectively. Fluores- dissociated. After incubating them in the presence of DiI-acetylated
cence of DiI was analyzed under the same condition for detecting LDL, the cells were stained with APC-anti-VE-cad and FITC-anti-
PE. As shown in this figure, the entire VE-cad1 cells shifted to the CD31. The cells expressing all three markers were sorted and sub-
right after staining with CD31 or Flk1 or incubating with DiI-ace- jected to colony assay in type I collagen gel in the presence or
tylated LDL. In contrast, by CD34 staining, a small proportion of absence of a mixture of SCF, IL-3, G-CSF, and erythropoietin. Each
cells did not shift to the right. These staining patterns indicate that dish (3 cm) received 2 ml of medium containing 2500 cells. (A) After
almost all VE-cad1 cells in E9.5 embryos coexpress CD31 and Flk1 incubating 4 days, colonies of various shapes appeared. No colonies
and uptake-acetylated LDL, while a small proportion of them may were generated in the absence of the growth factor mixture (data not
not be positive in CD34 expression. shown). (B) Some dishes containing colonies were further stained by
May-GruÈ nwald-Giemsa solution. Both compact and diffuse colonies
were generated. Compact colonies consist of round mononuclear
cells (C), while polymorphnuclear cells and monocytes are found in
from the culture of CD451 cells than from the culture of diffuse colonies (E). Pictures of higher magnification (E and D) were
VE-cad1 cells, indicating that B lymphogenic potency made by computer processing with Adobe Photoshop software.
of YS cells is specifically enriched in the EC fraction Magnification: A and B, 340; C and D, 3200; D and E, 3800.
(Figure 5C).
In E10.5 embryos, both EC and HPC from YS as well
as the embryo proper generated B2201 cells (Figure 5A). to home to intact thymic lobes, we cut dGuo-treated
thymic lobes into four pieces, onto which EC or HPC
were inoculated and incubated for 15 days. ThymicT Lymphopoietic Potential of the EC Fraction
Results in the preceding section demonstrated B lym- lobes were repaired spontaneously during culture. In
each experiment, 104 unfractionated liver cells from E15phopoietic potential of EC from E9.5 embryo. To eluci-
date whether or not EC of 9.5 embryos bear the potential embryos were cultured under the same conditions. Be-
fore the appearance of hind limb-buds, HPC from neitherto give rise to T cells, E8.5±10.0 embryos were fraction-
ated into EC and HPC populations and subjected to YS nor the caudal half of the embryo proper could gener-
ate cells with the light scatter profile of lymphocytesthymic organ culture as described previously (Dou et
al., 1995). Expecting that EC would not have the ability (indicated by boxes). In contrast, EC from both regions
Lymphohemogenic Endothelial Cells
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Figure 5. B Lymphopoietic Potential of EC in
Embryos
(A) VE-cad1Lin2 and VE-cad-Lin1 cells in YS
and the caudal half of E8.5, 9.5, and 10.5 em-
bryos were sorted, and 5000 cells were cul-
tured with OP9 and IL-7. All cells were har-
vested, and round hemopoietic cells were
enumerated, 14 days later. Cell increase rate
against the input cell number was calculated
and is presented in each panel. Harvested
cells were stained with PE-anti-B220 and
FITC-anti-Gr1. No B2201 cells were observed
in cultures of E8.5 embryos. In E9.5 embryos,
defect of B cell genesis was found only in the
culture of HPC fraction from YS.
(B) Expression of IL-7Ra, sIgM, CD3, and CD4
in the culture of EC fraction from E9.5 YS.
Under this condition, no cells bearing the T
cell markers are detectable.
(C) VE-cad1 cells and CD451 cells were
sorted from E9.5 YS and cultured with OP9
and IL-7. Culture cells were harvested, and
the expression of B220 and Mac1 was ana-
lyzed with FACS Vantage, 15 days later. Cell
increase rate against the input cell number is
presented within eachpanel. B lymphopoietic
progenitors are enriched in VE-cad1CD452
population.
could give rise to cells in this lymphocyte gate, more 1). Even though VE-cad1 multipotent progenitors may
exist in theearly embryo, they should have differentiatedthan half of which were Thy11 (Figure 7, experiment 1).
4-fold more CD4/CD8 double and single positive cells to fully functional EC by E9.5. This conclusion is consis-
tent with a previous study of Breier et al. (1996). Second,were generated in the culture of EC from the caudal half
of embryos than that from YS, indicating that the former previous studies on the function of VE-cad indicated
that VE-cad expression is sufficient for rendering thecontains more EC with T lymphopoietic potential than
the latter. cells organized in the EC layer. Indeed, VE-cad is the
sole cadherin involved in the establishment of adher-Consistent with the results on B lymphopoietic poten-
tial, EC from E8.5 embryos could not give rise to T cells ence junction of EC (Lampugnani et al., 1995; Matsu-
yoshi et al., 1997; Vittet et al., 1997; Navarro et al., 1998).(Figure 7, experiment 2). When E10 embryos where hind
limb-buds had just appeared were collected and sub- Moreover, it was shown that even a truncated form of
VE-cad lacking b-catenin binding domain can functionjected to the same assay, T lymphopoietic potential of
EC was maintained in both regions. HPCfrom thecaudal to mediate homotypic adhesion (Navarro et al., 1995,
1998). Third, VE-cad1 cells in E9.5 embryos coexpresshalf of embryos but not that from YS could give rise
to T cells, indicating that HPC with T lymphopoietic EC markers such as CD31, CD34, and Flk1 and take up
acetylated LDL. In fact, our FACS analysis of embryos atpotential appear earlier in the embryo proper than YS
(Figure 7, experiment 2). This result on T lymphopoietic various stages demonstrates that none of the presently
available surface markers is more specific to ECthan VE-potential is consistent with the result on B lymphopoietic
potential (Figures 5 and 6) and confirms that HPC differ- cad (Figure 2 and our unpublished data). For example,
CD31, CD34, and Flk1 are expressed in HPC as well asentiated in the YS are not competent to give rise to
lymphocytes, though EC in the same site is competent. EC, as a proportion of CD451 cells express them. In
contrast, the expression of VE-cadand CD45 is mutually
exclusive. Moreover, a complete set of these four vascu-Discussion
lar markers is expressed only in VE-cad1 cells. Taken
together, VE-cad1CD452Ter1192 cells used in this studyDo Hematogenic EC Exist?
In this report, we demonstrated the lymphohematopoie- thus represent the fully functional EC that are integrated
in the EC layer of the vascular system, particularly whentic potential of VE-cad1CD452Ter1192 cells. If VE-cad
expression is the hallmark of EC, our findings provide they are sorted from E9.5 or E10.5 YS. Hence, our obser-
vation that VE-cad1Lin2 cells derived from embryos asthe first functional evidence for the existence of lympho-
hematopoietic EC. Thus, what should be discussed first late as E9.5±10.5 gave rise to lymphohematopoietic cell
lineage is the first and unequivocal demonstration ofis whether or not VE-cad1Lin2 cells represent EC. Al-
though it is difficult to rule out the existence of non-EC the presence of lymphohematopoietic EC. This further
suggests that histological pictures in which round cellsVE-cad1 cells, the following evidence suggests strongly
that VE-cad1 cells are indeed EC. First, our immunohis- are displayed as if they bud from the luminal wall of the
vascular system (Smith and Glomski, 1982; Tavian ettochemistry demonstrated that VE-cad is expressed ex-
clusively in the EC of E9.5 YS, though VE-cad1 cells do al., 1996) may indeed catch the process of HPC differen-
tiation from the established EC layer. Such HPC buddingnot form a complete EC layer in E7.5 embryos (Figure
Immunity
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demonstrated that this culture condition is effective in
inducing B cells from freshly isolated embryonic ecto-
derm and mesoderm (Kanatsu and Nishikawa, 1996).
Hence, this failure likely reflects the intrinsic potential
of EC present in E8.5 embryo rather than the culture
conditions. Thus, acquisition of lymphopoietic compe-
tency may be an independent event distinct from that
of hematopoietic competency during EC differentiation.
Likewise, EC generated in nonhematopoietic sites such
as the cranial region cannot give rise to hematopoietic
cells at all (our unpublished data), indicating that a di-
verse set of EC is generated during early embryogene-
sis. With respect to lymphohematopoietic potential, at
least three cell types may exist: nonhematopoietic, he-
matopoietic without lymphopoietic competency, and lym-
phohematopoietic EC. If environmental cues play a role
in determining theproportion of eachsubset, only meso-
derm that differentiates in the right time and place can
generate EC with multiple potentials. Recently, Eich-
mann et al. (1997) demonstrated that vascular endothe-
lial growth factor suppressed in vitro differentiation of
Flk11 cells to HPC. If the concentration of vascular en-
dothelial growth factor differs significantly among em-
bryonic regions, this could be a molecular mechanism
underlying the environmental regulation of fate determi-
nation during mesoderm differentiation to EC. FurtherFigure 6. Expression of B Cell±Specific Genes in the Culture of EC
study is needed to understand the molecular nature of theVE-cad1Lin2 and VE-cad2Lin1 cells were enriched from E9.5 YS
environmental cues for generating the diversity of EC.and the caudal half of the embryo proper, and 5000 cells were
cultured for 14 days with OP9 and IL-7. Cultured cells were har-
vested and total RNA was prepared for RT-PCR analysis of the
expression of RAG1, MB1, GATA1, and HPRT. Lane 1, VE-cad1Lin2 Origin of HPC with Lymphopoietic Potential
YS cells; lane 2, VE-cad2Lin1 YS cells; lane 3, VE-cad1Lin2 cells Our data indicate that YS and the embryo proper do
from the embryo proper; lane 4, VE-cad2Lin1 cells from the embryo
not differ in the lymphopoietic potential of EC, thoughproper; and lane M, a size marker.
somewhat higher activity to generate T cells is detected
in the embryo proper. Paradoxically, we also found an
embryonic stage when CD451 HPC in theembryo properhas been demonstrated only in large vessels in the AGM
region. However, we showed that more than 10% of VE- but not in YS are competent to give rise to lymphocytes.
If acquisition of hematopoietic and lymphopoietic com-cad1CD311 cells from E9.5 embryo generated colonies
in response to the mixture of hematopoietic factors. petencies requires distinct processes, an interpretation
of this paradoxical observation is that YS does not pro-Moreover, VE-cad1 cells from YS can give rise to HPC.
All of these findings indicate that HPC differentiation vide an effective environment for the acquisition of lym-
phopoietic competency during differentiation from ECfrom the EC layer is a common event in the early sites of
blood cell differentiation, be it YS or the embryo proper. to HPC. Alternatively, lymphopoietic HPC may not be
able to survive in the YS microenvironment, though the
presence of lymphopoietic HPC in E10.5 YS, be it gener-Diversity of Lymphohematopoietic Potential
among Newly Generated EC ated in situ or migrated from the embryo proper, sug-
gests that this possibility is unlikely. It is also possibleHere, we reported a situation in which cells with lympho-
poietic potential were enriched in EC rather than HPC. that YS is not the site of HPC generation from EC, al-
though they have the potential to give rise to lympho-In both YS and the caudal half of E9.5 embryos before
hind limb-buds appear, cells that are competent to give cytes under our culture conditions. If so, HPC in the YS
should be the progenies derived from the earliest waverise to T lymphocytes are enriched in the VE-cad1CD452
rather than VE-cad2CD451 fraction. Thus, the compe- of hematopoiesis from mesoderm or hemangioblast or
both during blood island formation, whereas those intency to generate lymphocytes appears earlier in EC
than HPC. the embryo proper are from EC. This model may be
more consistent with the previous model that hypothe-Our results also indicate that EC become competent
to differentiate into lymphocytes with a 1-day time lag sizes that the primitive hematopoiesis is generated in
YS from hemangioblasts, whereas the definitive hema-following the acquisition of hematopoietic potential.
This failure to generate lymphocytes from EC of E8.5 topoietic cells bud from the EC layer of the AGM (Dzier-
zak and Medvinsky, 1995; Dieterlen-Lievre et al., 1997).embryos may be due to a deficiency of ourculture condi-
tions for supporting the lymphoid differentiation of ear- In either model, differentiation from EC to HPC should
be regulated distinctively in the embryo proper and YS,lier progenitors. However, Nakano et al. (1994) showed
that a combination of OP9 feeder cells and IL-7 supports while that from mesoderm to EC occurs in a similar way
in the two regions. This conclusion supports the notionB cell generation from the totipotent ES cells. We also
Lymphohemogenic Endothelial Cells
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Figure 7. T Lymphopoietic Potential of EC in Embryos
(Experiment 1) VE-cad1Lin2 (EC) and VE-cad2Lin1 (HPC) fractions were sorted from YS and the caudal half of E9.5 embryos before appearance
of hind limb-buds. 300 EC or 1000 VE-cad2Lin1 HPC cells were inoculated onto dGuo-pretreated thymus lobes and incubated for 15 days.
Triplicate culture was set for each group and pooled at the time of assay. Numbers presented in each light scatter figure (the first column)
represent the event count detected in the lymphocyte gate indicated by the square. Cells in this gate were analyzed for Thy1 expression (the
second column). Expression levels of CD8/CD4 (the third column) and gd/ab T cell receptors (the fourth column) in Thy11 cells in the lymphocyte
gate are presented. As a positive control, 104 unfractionated fetal liver cells from E15 embryo were cultured under the same condition.
(Experiment 2) E8.5 embryos and E10 embryos with hind limb-buds were used for the assay. VE-cad1CD452 (EC) and VE-cad2CD452 (HPC)
cells were sorted from various portions of embryos and subjected to thymus organ culture. In this experiment, 1000 cells were inoculated to
each culture. After 15 days, thymus lobes of each group were pooled and analyzed for expression of either CD4/CD8 or ab/gd. The number
of events counted in the lymphocyte gate was presented in the panels of the light scatter profile. The culture of 104 unfractionated fetal liver
cells from E15 embryos were used as a positive control. No T lymphocytes are detected in the culture of EC from E8.5 embryos. In the E10
embryos, all fractions but HPC from YS can generate T cells.
that YS and the embryo proper differ in their ability to inducing lymphocytes from YS cells. Such a strict re-
quirement of the microenvironment for the differentia-generate HPC with lymphopoietic potential (Ogawa et
al., 1988; Muller et al., 1994; Dzierzak and Medvinsky, tion to lymphocytes might reflect the property of EC
rather than HPC.1995; Cumano et al., 1996; Medvinsky and Dzierzak,
1996). It should be noted, however, that our observation With respect to the problem of embryonic circulation
that may contribute to the interchange of cells with lym-is also compatible with reports arguing against the AGM
origin of the definitive hematopoiesis. Recently, Yoder phopoietic potency between YS and the embryo proper,
Cumano et al. (1996) performed an elegant tissue ex-et al. (1997) demonstrated that CD341c-Kit1 cells from
E9.0 YS as well as AGM can give rise to lymphocytes plant experiment to show that YS has no potential to
generate HPC with lymphopoietic potential. We agreeupon transfer to bone marrow±ablated neonatal mice.
Although they claimed that CD341c-Kit1 cells represent with Cumano et al. (1996) and also with Medvinsky and
Dzierzak (1996) in that YS is fated not to generate HPCHPC, our observation demonstrated clearly that CD341
c-Kit1 cells contain both CD451 and VE-cad1 fractions with lymphopoietic potential before E10. However, we
also showed that ECin YS do have lymphopoietic poten-(Figure 2). If the cell preparation used in the studies by
Yoder et al. (1997) was contaminated with EC fraction, tial. Thus, we want to emphasize that the issue to be
addressed in the future is the molecular mechanismsand if their experimental conditions are sufficient tosup-
port EC differentiation to lymphocytes, it is conceivable that fate lymphopoietic EC in YS incapable of generating
HPC with lymphopoietic competency, rather than inter-that they were able to generate lymphocytes from YS
cells. Yoder et al. (1997) emphasized the importance of change of HPC between two regions.
The origin of HPC with lymphogenic potential is anusing neonatal rather than adult mice as the hosts for
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used for PE. The procedure for whole-mount immunohistostainingissue dealing with developing tissues whose cellular
was described previously (Takakura et al., 1997).composition is changing dynamically. In such tissues,
the potential and fate of each cellular component may
Culture with OP9 Stromal Cell Lineoften be dissociated, thereby rendering the fate analysis
For generating erythroid cells, 5000 sorted cells were cultured with
difficult. We believe that such a situation can be ana- OP9 stromal cell line with aMEM medium (GIBCO) containing 5 3
lyzed properly by evaluating both fate and potential of 1025 M 2-mercaptoethanol, 2 U/ml erythropoietin (a gift from Kirin
each individual component. Here, we present an exam- Co. Ltd) and 100 ng/ml SCF (Kodama et al., 1994; Nakano et al.,
1994). Erythroid precursors expressing Ter119 were evaluated byple showing that VE-cad1 and CD451 components in the
FACS Vantage 5 days after the culture. Assay for B and myeloidYS display distinctive lymphohematopoietic potentials,
cell lineage was performed by culturing 5000 cells with OP9 andthereby providing a clue as to why mutually conflicting
200 U/ml IL-7. Triplicate cultures were set for each assay. Cells were
results have been obtained. Moreover, our observation harvested, pooled, counted, and analyzed for the proportions of
strongly suggests that fate determination during differ- B2201 and Gr11 or Mac11 cells 14 to 15 days later. In some experi-
entiation from mesoderm, EC, and HPC is determined ments, surface expression of IL-7Ra and IgM was assessed.
by environmental components developing in parallel.
This is demonstrated also in the recent study of Turpen RT-PCR Analysis
Total cellular RNA was isolated from cultured cells using Isogenet al. (1997) in which different regions with hematopoi-
(Nippon Gene, Japan). First strand cDNA was prepared by reverseetic potential were transplanted in various sites of frog
transcription according to the protocol provided by the manufac-embryos. While the transplantation of embryonic tissues
turer (Perkin Elmer Cetus, Norwalk, CT). Oligo (dT)-primed cDNA
is difficult to perform in the murine embryo, the method was prepared from total RNA derived from 2 3 105 cells using avian
to separate intermediate stages during differentiation myeloblastosis virus reverse transcriptase in a reaction volume of
from multipotent mesoderm to committed HPC can be 20 ml under conditions recommended by the manufacturer (GIBCO-
BRL). PCRconditions were optimized for each primer set to maintainutilized to study the molecular mechanisms underlying
amplification in the linear range. Primer pairs were as follows: RAG1,environmental regulation of the commitment to HPC
59 sequence (59) 5-TGCAGACATTCTAGCACTCTGG-3 and 39 se-with lymphogenic potential.
quence (39) 5-ACATCTGCCTTCACGTCGAT-3; Mb1, (59) 5-GCCAG
GGGGTCTAGAAGC-3 and (39) 5-ACATCTGCCTTCACGTCGAT-3;
Experimental Procedures GATA1, (59) 5-AGTGCTGGGATTACAGGCAT-3 and (39) 5-TCATGGT
GGTAGCTGGTAGC-3; and HPRT (59) 5-GAGCTACTGTAATGATCAG
Cell Preparation TCAACGG-3 and (39) 5-GATTCAACTTGCGCTCATCTTAGGC.
Embryos were obtained and staged as previously described (Ka-
natsu and Nishikawa, 1996; Takakura et al., 1997). In this study,
High-Oxygen Thymic Organ CultureE8.5, E9.5, and E10 stand for embryos with 5±10 somites, 20±30
T lymphogenic potency was assessed by using high-oxygen thymussomites and fore limb-buds only, and both fore and hind limb-buds,
organ culture as described previously (Dou et al., 1995). EC (300)respectively. For dissection, YS was removed from the embryo
or HPC (1000) were cultured in each dGuo (Sigma)-treated thymicproper, and the remaining embryo was cut in half at the level below
lobe in the presence of 100 ng/ml SCF. Before cell inoculation,the heart. The caudal half of this prepared embryo was used as the
thymus lobes were cut into four pieces to facilitate the migration ofembryo proper. Dissected YS and the caudal half of embryos were
cells that may not be able to migrate through the capsule. Thesefirst incubated with dispase II solution (2.4 U/ml) (Boehringer Mann-
cuts were cured spontaneously during incubation. Triplicate cul-heim, Germany) in phosphate-buffered saline, washed once, and
tures were set for each assay. Lobes (three) were harvested, pooled,subsequently incubated with cell dissociation buffer containing
and split into two aliquots 15 days later. Each aliquot was two-colorEDTA/EGTA (Cat. No. #13150±016, GIBCO-BRL, Rockville, MD).
stained with CD8(FITC)/CD4(PE) or gd(FITC)/ab(PE) or three-colorCells were dissociated by gentle pipetting in this solution and then
stained with CD8(FITC)/CD4(PE)/Thy1(APC) or gd(FITC)/ab(PE)/washed with phosphate-buffered saline containing 5% fetal calf
Thy1(APC) mAb mixtures and analyzed using FACS Vantage. Onlyserum. Large cell clumps were removed with a nylon mesh.
cells with the light scatter profile of lymphocytes were counted and
analyzed. In each experiment, 104 liver cells from E15 embryos were
Antibodies
cultured as a positive control.
Anti-VE-cad (VECD1) (Matsuyoshi et al., 1997), anti-Flk1 (AVAS12)
(Kataoka et al., 1997), anti-IL-7Ra (Sudo et al., 1993) and anti-c-Kit
Colony Formation of Hematopoietic Cells(ACK2) (Nishikawa et al., 1991) mAb were prepared and conjugated
in Type I Collagen Gelto either biotin, R-phycoerythrin (PE), or FITC (all from Molecular
a-MEM containing 0.09% type I collagen was used as a semisolidProbes, Eugene, Oregon) as described previously (Nishikawa et al.,
medium for colony assay (Kodama et al., 1994). For colony assay,1991; Ogawa et al., 1991). Unconjugated, FITC-conjugated, or PE-
2 ml of medium containing 2500 cells was placed in a 3 cm dishconjugated anti-B220, anti-Gr1, anti-IgM, anti-CD31, anti-CD34,
that was kept on ice. After addition of a growth factor mixture con-anti-CD4, anti-CD8, anti-gd, anti-ab mAb, and apophycocyanin
taining 100 ng/ml SCF, 200 U/ml IL-3, 100 ng/ml G-CSF, and 2(APC)-conjugated anti-Thy1 mAb were purchased from Pharmingen
U/ml erythropoietin, the dish was transferred to 378C to polymerize(San Diego, CA).
collagen. Colonies were counted by inverted microscope 4 days
after the initiation of culture. To perform cytological analysis, theSurface Staining, Cell Sorting, and Immunohistochemistry
medium in the dish was blotted off by blotting papers through aFor surface staining, cell suspensions were incubated on ice in the
sheet of cellulose membrane (Clean Wipe-P, Asahi Kasei Co. Ltd,presence of various mixtures of labeled mAb. When biotin-conju-
Japan) placed on the surface of the gel. This thin film of collagengated mAb were used, they were washed and incubated with strep-
gel±containing colonies was dried and subjected to cytological anal-tavidin conjugated to either PE or APC. Labeled cells were resus-
ysis with May-GruÈ nwald-Giemsa staining.pended in Hank's balanced salt solution containing 1% bovine
serum albumin and propidium iodide and analyzed with FACS Van-
tage (Becton Dickinson, San Jose, CA). Dead cells stained with Acknowledgments
propidium iodide were excluded. Cell sorting was performed as
described previously (Ogawa et al., 1991). In some experiments, We thank N. Matsuyoshi for VECD1 mAb and L. Zon and S. Fraser
for critical reading of the manuscript. This study is supported bydissociated cells were first incubated with 10 mg/ml DiI-acetylated
LDL (Molecular Probes) for 4 hr and then stained with mixtures of grants from the Ministry of Education, Science, Sports, and Culture
of Japan (No. 07CE2005, 06277102, 06NP1101).mAb. Fluorescence of DiI was detected under the same conditions
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